Selenium-doped carbon quantum dot with endoplasmic reticulum targeting function as well as preparation method and application of selenium-doped carbon quantum dot
By amidating the MOA molecule with selenium-doped carbon quantum dots, a modified selenium-doped carbon quantum dot with endoplasmic reticulum targeting function was prepared, which solved the problem that carbon quantum dots cannot specifically remove the cell organelles in the prior art. The problem of ROS has achieved efficient clearance and inflammation relief of the endoplasmic reticulum area.
Patent Information
- Application Number
- CN202411057674.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-02
- Publication Date
- 2024-12-03
Smart Images

Figure CN119055783A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of functional materials, and in particular relates to selenium-doped carbon quantum dots with endoplasmic reticulum targeting function, and a preparation method and application thereof. Background Art
[0002] In a normal cellular environment, intracellular oxygen species (ROS) are regulated and kept in balance by oxidoreductase and non-enzymatic antioxidant systems. The appropriate amount of ROS generated is of great significance to physiological processes such as signal transduction, cell-mediated immunity and cellular redox balance. However, in some cases, such as anemia, long-term ultraviolet radiation or excessive intake of food additives, ROS may be overproduced, leading to oxidative stress and organ damage, and even serious diseases. Therefore, in order to maintain the normal physiological function of the body, it is necessary to establish reliable and effective methods to remove overproduced ROS.
[0003] So far, many antioxidants based on nanomaterials, including cerium dioxide nanoparticles, polydopamine nanoparticles, graphene nanoparticles, iridium nanoparticles, biomacromolecules, metal-organic frameworks, carbon nitride nanosheets and carbon nanoparticles, have been tried for the treatment of ROS-related injuries and diseases. Among them, carbon quantum dots are a new type of fluorescent carbon nanomaterials. In recent years, they have attracted much attention due to their excellent biological and optical properties, and have been widely used in biosensing, bioimaging, drug delivery and antioxidants. For example, Zhang et al. developed a nitrogen and sulfur co-doped CDs to reduce the oxidative stress response caused by ROS to cells (ACS Appl. Nano Mater., 2018, 1, 2699-2708). Rosenkrans et al. synthesized Se-doped CDs, demonstrated its antioxidant properties and used it for the specific treatment of renal injury (Adv. Sci., 2020, 7, 2000420). Chen et al. prepared tellurium-doped CDs to consume intracellular ROS and protect cells from H2O2 (Sci. Bull., 2020, 65, 1580-1586). However, the CDs synthesized in these works do not have a targeting function and cannot specifically remove ROS in each organelle. These works show that CDs can reduce the oxidative damage caused by ROS, which has a good guiding role in the development of CDs-based antioxidants and their practical application in the biomedical field. In addition, because ROS has extremely high reactivity and a very short half-life, it is necessary to remove ROS in time in the area where ROS is generated, that is, to remove ROS in situ to reduce the damage caused by ROS. For these reasons, it is particularly important to develop antioxidants with targeted functions.
[0004] The endoplasmic reticulum (ER) is a key player in protein synthesis, processing and transport as well as in maintaining Ca 2+The ER is a balanced organelle and the largest organelle in the cell. It is very sensitive to the imbalance of the internal cell environment. When ROS are excessively generated in the ER, it will trigger the ER stress response, which is closely related to many metabolic diseases such as diabetes, obesity and insulin resistance. Therefore, in order to maintain the normal state and function of the ER, it is of great physiological significance to design antioxidants with ER targeting ability to accurately remove excess ROS produced in the ER area. However, ER-targeted antioxidants have not been reported yet.
[0005] Therefore, there is an urgent need for a probe molecule with excellent ROS scavenging ability, low cytotoxicity, and excellent ER targeting ability. Summary of the invention
[0006] The technical problem to be solved by the present invention is to provide a selenium-doped carbon quantum dot with endoplasmic reticulum targeting function and its preparation method and application, and in particular to a selenium-doped carbon quantum dot with excellent ROS scavenging ability, low cytotoxicity, and excellent ER targeting ability, which is used as an antioxidant to alleviate or treat ROS-related diseases.
[0007] The invention provides a modified selenium-doped carbon quantum dot. The modified selenium-doped carbon quantum dot contains 3-(N-p-sulfobenzamide)-ethylamino-3-oxopropionic acid ethyl ester MOA grafted modified selenium-doped carbon quantum dots.
[0008] The present invention provides a method for preparing modified selenium-doped carbon quantum dots, comprising:
[0009] Selenium-doped quantum dots, 3-(N-p-sulfobenzamide)-ethylamino-3-oxopropionic acid ethyl ester MOA, and a catalyst are reacted to obtain modified selenium-doped carbon quantum dots, that is, MOA-modified selenium-doped carbon quantum dots with endoplasmic reticulum targeting function.
[0010] The selenium-doped quantum dots are added to a MOA solution, a catalyst is added, and the mixture is reacted at room temperature for a certain period of time to obtain MOA-modified selenium-doped carbon quantum dots with endoplasmic reticulum targeting function.
[0011] Preferably, the catalyst is 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide; the mass ratio of the selenium-doped quantum dots to MOA is 0.5:1-4:1; the mass ratio of the catalyst to the reactant (the reactant refers to the selenium-doped quantum dots and MOA) is 0.5:1-1:1.
[0012] Preferably, the reaction temperature is 25°C-60°C, and the reaction time is 12h-24h.
[0013] The preparation of the selenium-doped quantum dots comprises: mixing and completely dissolving a selenium-containing element precursor and water to obtain a solution, and transferring the solution to a high-pressure reactor for hydrothermal reaction to obtain selenium-doped quantum dots.
[0014] The selenium-containing precursor includes one or more of selenocysteine, selenocystine, and selenocystamine; the mass percentage concentration of the selenium-containing precursor in the solution is 0.1-1.0%; the water is double distilled water;
[0015] The hydrothermal reaction temperature is 160°C-200°C, and the time is 60min-240min.
[0016] The preparation of MOA comprises: adding N-(2-aminoethyl)-4-methylbenzenesulfonamide and methyl malonate chloride to a solvent and a saturated sodium bicarbonate solution for reaction, then adding a lithium hydroxide solution, and further reacting to obtain a carboxyl-containing endoplasmic reticulum targeting molecule 3-(N-p-sulfobenzamide)-ethylamino-3-oxopropionic acid ethyl ester MOA.
[0017] The molar ratio of N-(2-aminoethyl)-4-methylbenzenesulfonamide and methyl malonate chloride is 1:1-1:1.1; the solid content of the reactants (specifically referring to the percentage of N-(2-aminoethyl)-4-methylbenzenesulfonamide and methyl malonate chloride in the total mass of the solution during the preparation of MOA) is 5wt%-15wt%.
[0018] The ratio (volume ratio) of the solvent to the saturated sodium bicarbonate solution is 5:1-3:1; the concentration of the lithium hydroxide solution is 1-3M, and the volume ratio of the lithium hydroxide solution to the solvent is 1:5-1:3; wherein the solvent is tetrahydrofuran.
[0019] The reaction temperature is 0°C-30°C, and the total reaction time is 12h-30h.
[0020] Furthermore, N-(2-aminoethyl)-4-methylbenzenesulfonamide and methyl malonate chloride are added to a solvent tetrahydrofuran and a saturated sodium bicarbonate solution and reacted at 0°C for 0.5 to 3 hours, and then a lithium hydroxide solution is added and further reacted at room temperature for 12 to 24 hours to obtain a carboxyl-containing endoplasmic reticulum targeting molecule 3-(N-sulfobenzamide)-ethylamino-3-oxopropionic acid ethyl ester MOA.
[0021] The present invention provides an application of a modified selenium-doped carbon quantum dot probe in the field of biological monitoring, such as using the modified selenium-doped carbon quantum for active oxygen monitoring.
[0022] The present invention provides an application of the modified selenium-doped carbon quantum dots in preparing materials for removing excess active oxygen produced in the endoplasmic reticulum region and materials for alleviating or treating inflammation.
[0023] The invention prepares surface amino-functionalized selenium-doped carbon quantum dots by a hydrothermal method; synthesizes endoplasmic reticulum targeting functional molecules containing carboxyl functional groups, 3-(N-p-sulfobenzamide)-ethylamino-3-oxopropionic acid ethyl ester (MOA); and covalently grafts the obtained MOA molecules to selenium-doped carbon quantum dots by amidation reaction to obtain selenium-doped carbon quantum dots with endoplasmic reticulum targeting function. The quantum dots have good colloidal stability, excellent free radical scavenging ability, low cytotoxicity, and excellent endoplasmic reticulum targeting ability, and can be used for active oxygen scavenging and anti-inflammatory in vivo.
[0024] Beneficial Effects
[0025] (1) The present invention provides a selenium-doped carbon quantum dot with endoplasmic reticulum targeting function, the preparation method is simple, and the obtained product has the characteristics of good colloidal stability, strong free radical scavenging ability, low cytotoxicity, and excellent endoplasmic reticulum targeting ability;
[0026] (2) The present invention also provides a selenium-doped carbon quantum dots with endoplasmic reticulum targeting capability for targeted removal of endoplasmic reticulum ROS in vivo, which can effectively remove excess ROS generated in the endoplasmic reticulum and relieve inflammation in the body. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] Figure 1 This is the H NMR spectrum of the MOA molecule synthesized in Example 1 of the present invention.
[0028] Figure 2 This is the NMR carbon spectrum of the MOA molecule synthesized in Example 1 of the present invention.
[0029] Figure 3 This is a TEM image of the selenium-doped carbon quantum dots with endoplasmic reticulum targeting function obtained in Example 1 of the present invention.
[0030] Figure 4 These are infrared spectra of (a) selenium-doped carbon quantum dots, (b) MOA molecules, and (c) MOA-modified selenium-doped carbon quantum dots in Example 1 of the present invention.
[0031] Figure 5 The results are as follows: (a) DMPO (50 mM) was added with ·OH (10 μM) and different concentrations of MOA modified selenium-doped carbon quantum dots (bf: 10, 20, 30, 40 and 50 μg mL -1 ) after the EPR spectrum.
[0032] Figure 6This is a study on the distribution of HeLa cells in organelles after staining with modified carbon quantum dots and ER-Tracker Red in Example 2 of the present invention. (A) Blue fluorescence image of modified carbon quantum dots, (B) Red fluorescence image of ER-Tracker Red, (C) Merged image of A and B, (D) Bright field image of cells, (E) Correlation graph of emission intensity between blue channel and red channel, (F) Fluorescence intensity distribution of the straight line in C.
[0033] Figure 7 (A) is a fluorescent image of a mouse treated with DCFH-DA alone at the right ear in Example 3 of the present invention. (B) is a fluorescent image of a mouse treated with PMA and DCFH-DA. (C) is a fluorescent image of a mouse treated with PMA (100 μg mL -1 ,50μL), ER-Se-CDs (20μg mL -1 Fluorescence imaging of mice treated with PMA (100 μg mL -1 ,50μL), ER-Se-CDs (40μg mL -1 Fluorescence imaging of mice after treatment with 5-nitro-dioxin (1 μg / mL) and 4-nitro-dioxin (1 μg / mL). DETAILED DESCRIPTION
[0034] The present invention will be further described below in conjunction with specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the content taught by the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms fall within the scope limited by the appended claims of the application equally.
[0035] Example 1
[0036] This Example 1 provides the preparation of selenium-doped carbon quantum dots with endoplasmic reticulum targeting function.
[0037] S1. Add 0.1 g of selenocystamine to 40 mL of double distilled water and stir rapidly. After it is completely dissolved, transfer the solution to a high-pressure reactor lined with polytetrafluoroethylene, and heat the reaction at 200° C. for 2 h to obtain selenium-doped carbon quantum dots.
[0038] S2. Add 20 mL of tetrahydrofuran and 5 mL of saturated sodium bicarbonate solution to a 100 mL round-bottom flask, and dissolve N-(2-aminoethyl)-4-methylbenzenesulfonamide (1.0 g, 4.7 mmol) and methyl malonate chloride (0.7 g, 5.1 mmol). After the mixed solution reacts at 0°C for 1 h, inject LiOH solution (2M, 5 mL) and react at room temperature for another 12 h. Then remove the solvent by vacuum distillation to obtain the MOA molecule. Its H NMR spectrum and C NMR spectrum are as follows: Figure 1 and Figure 2 shown.
[0039] S3, 2 mg of selenium-doped carbon quantum dots were added to the MOA solution (1.0 mL, 1.5 mM), followed by 50 mg of EDC and 50 mg of NHS, and reacted at room temperature for 12 h. After the reaction was completed, the excess MOA was removed by dialysis, and MOA-modified Se-CDs were obtained after freeze-drying.
[0040] The TEM images of the obtained MOA-modified selenium-doped carbon quantum dots are shown in Figure 3 As shown, the size of quantum dots is between 2.4-3.2nm, and the average size is about 2.8nm.
[0041] The infrared spectra of unmodified selenium-doped carbon quantum dots, MOA molecules, and selenium-doped carbon quantum dots modified with MOA molecules are shown in Figure 2. Figure 4 As shown, it indicates that the MOA molecules were successfully grafted onto the carbon quantum dots.
[0042] Example 2
[0043] This Example 2 provides verification of the free radical scavenging ability and targeting ability of selenium-doped carbon quantum dots with endoplasmic reticulum targeting function.
[0044] When Fe 2+ After adding / H2O2 to the 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) solution, the characteristic electron paramagnetic resonance (EPR) signal peak of DMPO-OH adduct was detected, indicating the presence of high concentration of hydroxyl radicals (·OH). After treatment with modified quantum dots, the EPR signal intensity of the mixture weakened, and the more modified quantum dots were added, the more obvious the signal weakening was, indicating that the probe has a good scavenging effect on ·OH ( Figure 5 ).
[0045] The modified carbon quantum dots and the commercial endoplasmic reticulum dye ER-Tracker Red were used to treat the cells simultaneously and then a confocal experiment was performed to verify the endoplasmic reticulum targeting function of the modified carbon quantum dots. Figure 6 As shown, Figure 6 The blue signal in A corresponds to the fluorescence signal of the modified carbon quantum dots. Figure 6The red signal in B corresponds to the fluorescence signal of ER-Tracker Red. Figure 6 C is the superposition of the two. Figure 6 In C, it can be seen that the blue signal and the red signal are highly overlapped, and the corresponding Pearson coefficient is 0.87 ( Figure 6 E), indicating that the modified carbon quantum dots have good targeting to the endoplasmic reticulum. Figure 6 F also shows that the fluorescence signals of ER-Se-CDs and ER-Tracker Red almost overlap. This group of fluorescence imaging experiments showed that the modified carbon quantum dots selectively localized to the ER region.
[0046] Example 3
[0047] This example provides the scavenging and verified elimination effect of modified carbon quantum dots on active oxygen in mice. The right ear epidermis of mice was treated with phorbol 12-myristate 13-acetate (PMA) to induce ear inflammation in mice. Figure 7 As shown in A, no obvious fluorescence was found in the right ear of the control group mice (treated only with 2'7'-dichlorofluorescein diacetate (DCFH-DA)), indicating that the ROS level in normal mice is low. When treated with DCFH-DA and PMA at the same time, a strong fluorescence signal was generated in the right ear of the mouse, indicating an increase in ROS level during this process ( Figure 7 B). After subcutaneous treatment with modified carbon quantum dots, the fluorescence signal intensity of the inflamed ear dropped dramatically ( Figure 7 C and Figure 7 D), indicating a reduction in the level of ROS in vivo. This experiment verifies the ability of modified carbon quantum dots to scavenge ROS in vivo and their anti-inflammatory effects.
Claims
1. A modified selenium-doped carbon quantum dot, characterized in that: The modified selenium-doped carbon quantum dots contain 3-(N-p-sulfobenzamide)-ethylamino-3-oxopropionic acid ethyl ester MOA grafted modified selenium-doped carbon quantum dots.
2. A method for preparing modified selenium-doped carbon quantum dots, comprising: Selenium-doped quantum dots, 3-(N-p-sulfobenzamide)-ethylamino-3-oxopropionic acid ethyl ester MOA and a catalyst are reacted to obtain modified selenium-doped carbon quantum dots.
3. The preparation method according to claim 2, characterized in that: The catalyst is 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide; the mass ratio of the selenium-doped quantum dots to MOA is 0.5:1-4:1; and the mass ratio of the catalyst to the reactant is 0.5:1-1:
1.
4. The preparation method according to claim 2, characterized in that: The reaction temperature is 25°C-60°C, and the reaction time is 12h-24h.
5. The preparation method according to claim 2, characterized in that: The preparation of the selenium-doped quantum dots comprises: mixing a selenium-containing element precursor and water to obtain a solution, and performing a hydrothermal reaction to obtain the selenium-doped quantum dots.
6. The preparation method according to claim 5, characterized in that: The selenium-containing precursor includes one or more of selenocysteine, selenocystine, and selenocystamine; the mass percentage concentration of the selenium-containing precursor in the solution is 0.1-1.0%; the water is double distilled water; The hydrothermal reaction temperature is 160°C-200°C, and the time is 60min-240min.
7. The preparation method according to claim 2, characterized in that: The preparation of MOA comprises: adding N-(2-aminoethyl)-4-methylbenzenesulfonamide and methyl malonate chloride to a solvent and a saturated sodium bicarbonate solution for reaction, then adding a lithium hydroxide solution, and further reacting to obtain 3-(N-p-sulfobenzamide)-ethylamino-3-oxopropionic acid ethyl ester MOA.
8. The preparation method according to claim 7, characterized in that: The molar ratio of N-(2-aminoethyl)-4-methylbenzenesulfonamide to methyl malonate chloride is 1:1-1:1.1; the solid content of the reactants is 5wt%-15wt%; The volume ratio of the solvent to the saturated sodium bicarbonate solution is 5:1-3:1; the concentration of the lithium hydroxide solution is 1-3M, and the volume ratio of the lithium hydroxide solution to the solvent is 1:5-1:3; the solvent is tetrahydrofuran; The reaction temperature is 0°C-30°C, and the reaction time is 12h-30h.
9. Application of modified selenium-doped carbon quantum dots in the field of biological monitoring.
10. Use of the modified selenium-doped carbon quantum dots according to claim 1 in preparing materials for removing active oxygen, relieving or treating inflammation.
